Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications
Yunlong Qin
, Xinghua Chen
,
Itamar Willner
*
*
Corresponding author for this work
Institute of Chemistry
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nucleic Acids
100%
Acid Modified
100%
Cancer Therapeutics
100%
Modified Nanoparticles
100%
Therapeutic Applications
100%
Oligonucleotides
75%
Cancer Cells
75%
Cancer Treatment
75%
Nanoparticle Conjugate
75%
Nanomaterials
50%
Gene Therapy
25%
Therapeutic Treatment
25%
Conjugation
25%
Reconfiguration
25%
Nanoparticles
25%
Synergistic Properties
25%
Active Surface
25%
Polymer Nanoparticles
25%
Photocatalytic Activity
25%
Specific Recognition
25%
Metal-organic Frameworks (MOFs)
25%
Stimuli-responsive
25%
Hybrid Nanostructures
25%
High Loading Capacity
25%
Medical Applications
25%
Molecular Agents
25%
Recognition Function
25%
Chemotherapeutic Treatment
25%
Photothermal Therapy
25%
Surface Interface
25%
Catalytic Function
25%
Metal Oxide Nanoparticles
25%
Photodynamic Treatment
25%
Cell Permeability
25%
Hybrid Composites
25%
Carbon Dots (C-dots)
25%
Functional Interface
25%
Porous Nanoparticles
25%
Photocatalytic Nanoparticles
25%
Therapy Treatment
25%
Catalytic Nanoparticles
25%
Targeting Cells
25%
Nanosynthesis
25%
Chemodynamic
25%
Material Science
Nanoparticle
100%
Nucleic Acid
100%
Nanostructured Material
25%
Metal Oxide
12%
Gene Therapy
12%
Carbon Quantum Dot
12%
Nanostructure
12%